英文别名 |
LY2857785;LY-2857785;(1r,4r)-N1-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-N4-(tetrahydro-2H-pyran-4-yl)cyclohexane-1,4-diamine;4-N-[4-(2-methyl-3-propan-2-ylindazol-5-yl)pyrimidin-2-yl]-1-N-(oxan-4-yl)cyclohexane-1,4-diamine;BCP24053;BDBM50193097;s7511;SB18859;B8002;trans-N1-(4-(3-Isopropyl-2-methyl-2H-indazol-5-yl)pyrimidi;CID 78357764;LY2857785
(LY 2857785;1,4-Cyclohexanediamine, N1-[4-[2-methyl-3-(1-methylethyl)-2H-indazol-5-yl]-2-pyrimidinyl]-N4-(tetrahydro-2H-pyran-4-yl)-, trans-;trans-N1-(4-(3-Isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-N4-(tetrahydro-2H-pyran-4-yl)cyclohexane-1,4-diamine;Cyclin dependent kinase,LY 2857785,CDK,Apoptosis,LY2857785,Inhibitor,inhibit,LY-2857785;NCGC00390634-01;LY-2857785;LY 2857785;N1-[4-(3-isopropyl-2-methylindazol-5-yl)pyrimidin-2-yl]-N4-(oxan-4-yl)cyclohexane-1,4-diamine;CS-3336;NCGC00390634-02;BRD-K15382985-001-01-7;CCG-269222;AC-35707;1619903-55-7;SCHEMBL25994330;CHEMBL3940387;1619903-54-6;(1R,4R)-N1-[4-(3-ISOPROPYL-2-METHYLINDAZOL-5-YL)PYRIMIDIN-2-YL]-N4-(OXAN-4-YL)CYCLOHEXANE-1,4-DIAMINE;EX-A1714;phen-IA;SCHEMBL24977557;HY-12293;BS-15873;AKOS030526612 |